Company intelligence / Profile preview

Novafem

Ownership: Private
Development stage: Commercial

Overview

Novafem is an established Colombian medical center specializing in high and low complexity assisted reproduction procedures. They offer comprehensive diagnostic protocols and personalized care to maximize success rates for patients seeking fertility solutions. Their approach includes the "Novafem Protocol," designed to optimize decision-making and outcomes for patients undergoing treatment[2][3]. The company has participated as a sponsor/collaborator in at least one published clinical study related to oocyte quality post-SARS-CoV‑2 infection/vaccination[1].

Therapeutic areas: Women's Health
Modalities: Non-pharmacological therapyDevice (assisted reproduction technologies)Hormone (in context of fertility treatments)
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Novafem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novafem.

Explore the full profile